Unblinding was the major issue in @Lykos_PBC MDMA efficacy review by @US_FDA's PDAC
In 2011 I started a post-doc with ayahuasca and figured out the obvious: double-blinding wouldn't work. In 2014 I discussed this at @Imperial_PRG without success
We need better epistemology ๐งต๐
It is striking how the field of evidence-based medicine (EBM) continuously endorses blinding as the most reliable control for post-randomization biases, when in fact there's much evidence to systemic failures and epistemic bias, as I presented at PS23
Apr 11, 2023 โข 12 tweets โข 4 min read
7even years ago @PNASNews published results of our neuroimaging exploration with #LSD, bravely led daily by @RCarhartHarris and a young trio @LeorRoseman myself and @MendelKaelen in the early days of @Imperial_PRG, exploring unknown frontiers despite huge prejudice all around...
One day, with LSD inside my blood, I saw an unforgetable infinitude of things, including the MRI transform into a massive surgical robot laser-cutting thin slices of my brain which flew at light speed into the computer screen in the nearby room...
Mar 22, 2023 โข 12 tweets โข 7 min read
This equinox the @IPCC_CH released the updated edition of our best "manual for spaceship earth" ๐, nicely summarized by Prof. @KHayhoe here:
Should we build connections between our existential #climatecrisis and psychedelics?
๐งต๐
In a nutshell:
"a batata ๐ฅ ta assando ๐ฅ"
(the potato is roasting), as people say in Brazil ๐ง๐ท when facing complicated problems
Feb 16, 2023 โข 4 tweets โข 2 min read
This is likely the single most important paper in psychedelic science ๐ซ since "the LSD lid" (2017) and the "dmt-sigma 1" (2009) publications
This week #psychedelics, almost completely ignored by western science and medicine in the last quarter of the 20th century, made it to the top of ๐บ๐ธ healthcare, the @NIH:
4k folks ๐ 21 time zones
+10h of talks
Panelists from
๐บ๐ธ 12
๐จ๐ฆ 1
๐ฎ๐ฑ 1
๐ฉ๐ฐ 1
๐ฌ๐ง 1
๐ณ๐ฟ 1
๐จ๐ญ 1
๐งต summary ๐
Agenda comprised 3 main themes:
Basic and translational research ๐๐ฌ๐ฉโ๐ฌ๐จโ๐ฌ๐งฎ๐ป
Clinical trials ๐ฉโโ๏ธ๐งโโ๏ธ๐จโโ๏ธ๐คฎ๐๐ค๐
Optimising future trial designs ๐พ๐ฝ๐ฟ๐
Jan 13, 2022 โข 19 tweets โข 9 min read
Third and last session of #psychedelics@NIH ๐บ๐ฒ workshop starting now, looking at how to optimize clinical trials design and how to get these treatments approved ๐งต
Starting with Ido @hartogsohn ๐ฎ๐ฑ on psychedelic set and setting theory
Jan 13, 2022 โข 36 tweets โข 13 min read
Today is the second day of psychedelics @NIH ๐บ๐ฒ with a critical issue to be tackled:
Overcoming #EpistemicInjustices in the biomedical study of #ayahuasca: Towards #ethical and sustainable #regulation. New paper for โCultural context and ethical issues in the therapeutic use of psychedelicsโ special issue of Transcultural Psychiatry ๐งต1/
We (me and non-tweeter ๐ง๐ท PhD lawyer Konstantin Gerber) reviewed 4 decades of biomedical research about the sacred and ancient vine of the Amazon, documenting how biomedicine systematically commits a specific kind of injustice: against indigenous people as givers of knowledge. 2/
Jul 5, 2021 โข 16 tweets โข 6 min read
1/16 THREAD๐งต3 years ago I proposed that #Psychedelic-Assisted Psychotherapy (PAP) is a #ParadigmShift in psychiatry. The paper has been viewed almost 80k times around the globe and sits at the top 1% views/downloads and top 8% citations of the whole @FrontiersIn journal series.
2/16 Published in the special issue โPsychedelic Drug Research in the 21st Centuryโ it has 82 citations at Google Scholar and was included in one slide by Javier Muรฑiz, from the FDAโs division of psychiatry, at his ISRP lecture in Oct/2019 frontiersin.org/articles/10.33โฆ
Mar 15, 2021 โข 20 tweets โข 11 min read
1/18 This tweet completes two months today (and our paper 74 days). What happened since? [a non exhaustive psychedelic patenting thread]